/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Kantara Initiative And The CARIN Alliance Sign Affiliated Alliance Agreement
Will Collaborate On Assurance For Consumer Access To Health Care
Information
WAKEFIELD, Mass.–(BUSINESS WIRE)–Kantara
Initiative, the only industry organization focused on 3rd
party assessed digital identity and privacy assurance frameworks,
announced today the signing of an affiliated alliance agreement with the CARIN
Alliance, a non-partisan, multi-sector alliance of more than sixty
health care and other stakeholders managed by Leavitt Partners.
The agreement allows for collaboration and eventual development of
assurance schemes underpinning the Office of National Coordinator’s
(ONC) Trusted Exchange Framework and Common Agreement (TEFCA) to help
consumers and their authorized caregivers easily get, use, and share
their digital health information where, when, and how they want to
achieve their goals.
Opportunities exist for Kantara’s User-Managed
Access (UMA) 2.0 and Consent
Receipt 1.1 (CR 1.1) global technical specifications to be
implemented in organizations who desire to be in compliance with the
ONC’s draft TEFCA
for improved consumer access and control of health care data. Kantara’s
community developed UMA 2.0 and CR 1.1 specifications and Kantara’s
Trust Framework Operations bring user consent, control and trust into
easier reach for consumers and organizations accessing and processing
personal data.
“The CARIN Alliance plans to develop a set of best practices for
implementing the use of NIST 800-63-3 Identity Assurance Level 2 (IAL2)
and Authenticator Assurance Level 2 (AAL2) guidelines in
health care,” said Ryan Howells, principal at Leavitt Partners. “We were
the first major health care collaborative to recommend in August 2017
that ONC use the NIST 800-63-3 guidelines, including IAL2 and AAL2, as
the minimum identity proofing and authentication requirements in health
care. From the beginning, Kantara has played a key role in helping us
develop best practices and build an overall trust framework to implement
these open standards and help us drive forward our goal of enabling
consumers and their authorized caregivers to have more access to their
digital health information with less friction.”
Kantara is the only
3rd party-assessing Trust Framework Provider offering
assurance of conformance to NIST 800-63-3 and other de jure standards.
“Over the last decade, Kantara Initiative has led the way in developing
best practices and trust schemes in the digital identity and privacy
space with the goal of building cross-community trust and ensuring
people have control of their own data,” said Colin Wallis, executive
director, Kantara Initiative. “It is the meshing of the two that creates
solutions of real benefit to the end-user. Privacy and digital identity,
together, provide maximum value to the consumer. The CARIN Alliance
understands this and, together, we will work to help provide consumers
more control over their sensitive health care data.”
About Kantara Initiative
The Kantara Initiative is the
leading global consortium improving trustworthy use of identity and
personal data through innovation, standardization and good practice.
Kantara provides real-world innovation through its development of
specifications, applied R&D and conformity assessment programs for the
digital identity and personal data ecosystems. Kantara provides its
coveted eIDassisting Identity
Assurance Trust Mark and groundbreaking specifications for User
Managed Access, and the privacy enabling Consent
Receipt. More information is available at https://kantarainitiative.org/.
Follow
Kantara Initiative on Twitter
— @KantaraNews
About the CARIN Alliance
The CARIN Alliance is a
non-partisan, multi-sector alliance led by distinguished risk-bearing
providers, payers, consumers, electronic health record vendors,
pharmaceutical companies, consumer platform companies, digital health
companies, and consumer-advocates who are working collaboratively with
other stakeholders in government to overcome barriers in advancing
consumer-directed exchange across the U.S. The CARIN Alliance vision is
to rapidly advance the ability for consumers and their authorized
caregivers to easily get, use, and share their digital health
information when, where, and how they want to achieve their goals. For
more information, please visit www.carinalliance.com or @carinalliance on
Twitter.
Contacts
Bob Olson, Virtual, Inc.
+1.781.876.8839
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis4 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
SCHWAZZE5 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis4 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Humboldt4 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis2 days ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III